Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
06/2010
06/10/2010WO2010063824A1 Novel composition for treatment of essential thrombocythemia
06/10/2010WO2010063491A2 Transport-mediating colloidal pharmaceutical compounds
06/10/2010WO2010063483A2 Active ingredient-peptide construct for extracellular enrichment
06/10/2010WO2010063387A1 Extrudate having spicular active substances
06/10/2010WO2010063163A1 A patch of antiemetic agent
06/10/2010WO2010063124A1 Peptide therapeutic conjugates and uses thereof
06/10/2010WO2010063123A1 Leptin and leptin analog conjugates and uses thereof
06/10/2010WO2010063122A1 Conjugates of neurotensin or neurotensin analogs and uses thereof
06/10/2010WO2010045415A3 Topical nsaid compositions having sensate component
06/10/2010WO2010037878A9 Utilisation of nanoparticles of noble metals as immunomodulators and immunomodulator composition
06/10/2010WO2010036947A3 Lipid based pharmaceutical preparations for oral and topical application; their compositions, methods, and uses thereof
06/10/2010WO2010034853A8 Utilization of xylitol or its derivatives for taste-masking chemotherapy drugs of the quinolone-o-naphthyridone carboxylic acid group administrated in food intended for pigs
06/10/2010WO2010027513A3 Methods for killing psma-expressing, taxane-resistant cancer cells
06/10/2010WO2010011319A3 Magnetic heating for drug delivery and other applications
06/10/2010WO2010009111A4 A drug depot implantable within a synovial joint
06/10/2010WO2010004054A3 Nucleic acid comprising zwitterionic nucleotides
06/10/2010WO2010000348A3 Foaming skincare cream
06/10/2010WO2009134808A3 Supercharged proteins for cell penetration
06/10/2010WO2009065561A8 System for delivery into a xcr1 positive cell and uses thereof
06/10/2010WO2009056280A8 Antibodies which bind selectively to hair of animals and an antibody based drug delivery system for animals
06/10/2010US20100145252 Prevention of indwelling device related infection: compositions and methods
06/10/2010US20100145251 Prevention of indwelling device related infection: compositions and methods
06/10/2010US20100145018 Lipid-Polymer-Conjugates
06/10/2010US20100145017 Method of producing interferon-b complex
06/10/2010US20100144902 Biocompatible rapid-gelating hydrogel and associated preparation method of spray
06/10/2010US20100144901 Gel composition for medical material or hygiene material, molded article thereof and adhesive material or adhesive preparation using same
06/10/2010US20100144900 Stereo Photo Hydrofel, a Process of Making Said Stereo Photo Hydrogel, Polymers for Use in Making Such Hydrogel and a Pharmaceutical Comprising Said Polymers
06/10/2010US20100144899 Method for preparing nano-emulsions
06/10/2010US20100144897 Methicone replacements for cyclomethicone
06/10/2010US20100144896 Thixotropic pharmaceutical compositions
06/10/2010US20100144895 Embolic compositions with non-cyanoacrylate rheology modifying agents
06/10/2010US20100144894 Use of dicalcium phosphate anhydride powder
06/10/2010US20100144697 Stabilized pharmaceutical compositions containing a calcium channel blocker
06/10/2010US20100144696 Stabilized pharmaceutical compositions containing a calcium channel blocker
06/10/2010US20100144665 Treatment of statin side effects
06/10/2010US20100144637 Nucleic acid and corresponding protein entitled 161p5c5 useful in treatment and detection of cancer
06/10/2010US20100144635 Methods and compositions to treat myocardial conditions
06/10/2010US20100144593 Pharmaceutical Compositions and Methods for Insulin Treatment
06/10/2010US20100143962 Nanoparticulate polycosanol formulations & novel polycosanol combinations
06/10/2010US20100143493 Ophthalmic solutions
06/10/2010US20100143486 Polyethylene glycol-coated sodium carbonate as a pharmaceutical excipient and compositions produced from the same
06/10/2010US20100143485 Oxycontin controlled release formulations and methods of using same
06/10/2010US20100143481 Method of preparing solid dosage forms of multi-phasic pharmaceutical compositions
06/10/2010US20100143480 Tricalcium phosphate coarse particle compositions and methods for making the same
06/10/2010US20100143470 Controlled release pharmaceutical composition containing thiazides and angiotensin-ii-receptor blockers
06/10/2010US20100143456 Model membrane systems
06/10/2010US20100143314 In Vivo Production and Delivery of Erythropoietin or Insulinotropin for Gene Therapy
06/10/2010US20100143298 Colloidal metal compositions and methods
06/10/2010US20100143269 Pharmaceutical compositions for the treatment of asthma
06/10/2010US20100143260 Coating system
06/10/2010DE102008060904A1 Wasserlösliche Wirkstoffe in Sprühpflaster Water-soluble active ingredients in spray-on
06/10/2010CA2808320A1 Sparc binding peptides and uses thereof
06/10/2010CA2745923A1 Sparc binding scfvs
06/10/2010CA2745592A1 Transport-mediating colloid medicinal compounds
06/10/2010CA2745527A1 Leptin and leptin analog conjugates and uses thereof
06/10/2010CA2745524A1 Conjugates of neurotensin or neurotensin analogs and uses thereof
06/10/2010CA2745499A1 Peptide therapeutic conjugates and uses thereof
06/10/2010CA2745456A1 Extrudate having spicular active substances
06/10/2010CA2745414A1 Flowable pharmaceutical depot
06/10/2010CA2745411A1 Inhalant containing modified superoxide dismutase
06/10/2010CA2745123A1 Pharmaceutical suspension
06/09/2010EP2194096A1 Use of pectinate copolymers on the basis of acryloyldimethyl taurine acid in cosmetic, dermatological and pharmaceutical agents
06/09/2010EP2194080A1 Cosmetic, dermatological and pharmaceutical agent containing tensides
06/09/2010EP2194068A1 Cyclodextrin compound modified with folic acid, process for production thereof, drug delivery agent for targeting drug delivery system, pharmaceutical composition, and imaging agent
06/09/2010EP2193810A1 Meningococcal conjugate vaccination
06/09/2010EP2193809A1 Albumin-free factor VIII formulations
06/09/2010EP2193804A2 Recombinant adenylate cyclase toxin of bordetella induces T cell responses against tumoral antigens
06/09/2010EP2193798A1 Liquid crystal emulsion-type pharmaceutical composition containing cyclosporine, and method of treating cutaneous disease therewith
06/09/2010EP2193795A1 Latanoprost-containing aqueous pharmaceutical composition
06/09/2010EP2193791A1 The treatment of respiratory diseases
06/09/2010EP2193788A1 Pharmaceutical compositions comprising colloidal silicon dioxide
06/09/2010EP2193769A1 Patch material
06/09/2010EP2193204A2 Novel lipophilic compositions and uses thereof
06/09/2010EP2193147A1 Nucleotide and protein sequences of an antibody directed against an epitope common to human acidic and basic ferritins, monoclonal antibodies or antibody-like molecules comprising these sequences and use thereof
06/09/2010EP2193137A1 Organic/inorganic hybrid nanoparticulates made from iron carboxylates
06/09/2010EP2193136A1 Solid inorganic/organic hybrid with modified surface
06/09/2010EP2192924A2 Saccharide-containing protein conjugates and uses thereof
06/09/2010EP2192914A1 Polymeric linkers containing pyridyl disulfide moieties
06/09/2010EP2192893A2 Antifungal composition
06/09/2010EP1347789B1 Hot melt adhesives for dermal application
06/09/2010EP1292628B1 Process for the manufacture of hydrogel compositions and hydrogel compositions manufactured thereby
06/09/2010CN1943625B Oral sterilizing liquid
06/09/2010CN1939919B Low-toxic and broad-spectrum phthalocyanine bactericide, its production and use
06/09/2010CN1929818B Pimecrolimus foam composition containing hexylene glycol, optionally oleyl alcohol, dimethylisosorbide and/or medium chain triglycerides
06/09/2010CN1829742B Aminated complex-type sugar chain derivatives and process for the production thereof
06/09/2010CN1812813B Pharmaceutical compositions comprising peranhydrocyclodextrin
06/09/2010CN1780610B Pharmaceutical composition in the form of a hydrogel for transdermal administration of active substances
06/09/2010CN1679957B A pharmaceutical composition containing liposomes for treating a cancer
06/09/2010CN101730549A polymers conjugated with platinum drugs
06/09/2010CN101730548A Preserving secondary peptide structure
06/09/2010CN101730539A Fibrin gel for controlled release of tgf-beta and uses thereof
06/09/2010CN101730537A Pharmaceutical composition with antifungal activity containing cymbopogon nardus, its process, and use
06/09/2010CN101730526A Nanoparticle comprising rapamycin and albumin as anticancer agent
06/09/2010CN101730524A A foam material for medical use and method for producing same
06/09/2010CN101730523A Glp-1-fc fusion protein formulation
06/09/2010CN101730522A Pharmaceutical composition for topical application of poorly soluble compounds
06/09/2010CN101724916A Method for preparing pH-sensitive cellulose ether and ester medicament-carrying electrospinning fibers
06/09/2010CN101724163A Composite microsphere of chitosan derivative, preparing method and applications thereof
06/09/2010CN101724162A Preparation method of nano micellar solution of polymer with simulated cellulosa membrane structure
06/09/2010CN101724160A Copolymer of fibroin and poly L-lactic acid and melt polymerization preparation method and application thereof
1 ... 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 ... 1712